NCT07177430 Inspiratory Muscle Training in Children and Adolescents With Idiopathic Scoliosis Undergoing Schroth Therapy.
| NCT ID | NCT07177430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wroclaw University of Health and Sport Sciences |
| Condition | Scoliosis Idiopathic |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2025-10-13 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effectiveness of inspiratory muscle training in children and adolescents with idiopathic scoliosis undergoing therapy with the Schroth method. The intervention- inspiratory muscle training- aims to improve respiratory function, increase exercise tolerance, and strengthen core stability in the participants. The proposed training may enhance the effectiveness of therapy conducted using the Schroth method and improve participants' performance in activities of daily living. The project aims to assess the impact of inspiratory muscle training in children and adolescents with idiopathic scoliosis on respiratory system function, exercise tolerance, and core stability.
Eligibility Criteria
Inclusion Criteria: * diagnosed idiopathic scoliosis, * age: 11-16 years (girls after their first period, boys after voice mutation), * spinal curvature angle \> 20° according to Cobb, * guardian's consent to participate in the study; Exclusion Criteria: * chronic respiratory diseases, * inhalant allergies, * limited contact with the patient, preventing the examination from being performed;
Contact & Investigator
Krystyna Rożek-Piechura, Professor
STUDY DIRECTOR
Wroclaw University of Health and Sport Sciences, Poland
Frequently Asked Questions
Who can join the NCT07177430 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 16 Years, studying Scoliosis Idiopathic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07177430 currently recruiting?
Yes, NCT07177430 is actively recruiting participants. Contact the research team at aleksandra.grudzinska@awf.wroc.pl for enrollment information.
Where is the NCT07177430 trial being conducted?
This trial is being conducted at Wroclaw, Poland, Wroclaw, Poland.
Who is sponsoring the NCT07177430 clinical trial?
NCT07177430 is sponsored by Wroclaw University of Health and Sport Sciences. The principal investigator is Krystyna Rożek-Piechura, Professor at Wroclaw University of Health and Sport Sciences, Poland. The trial plans to enroll 56 participants.